Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 678

1.

The effects of orally administered Bifidobacterium animalis subsp. lactis strain BB12 on dextran sodium sulfate-induced colitis in mice.

Chae JM, Heo W, Cho HT, Lee DH, Kim JH, Rhee MS, Park TS, Kim YK, Lee JH, Kim YJ.

J Microbiol Biotechnol. 2018 Sep 20. doi: 10.4014/jmb.1805.05072. [Epub ahead of print]

2.

Semi-rational screening of the probiotics from the fecal flora of healthy adults against DSS-induced colitis mice by enhancing anti-inflammatory activity and modulating the gut microbiota.

Wang W, Xing W, Wei S, Gao Q, Wei X, Shi L, Kong Y, Su Z.

J Microbiol Biotechnol. 2018 Sep 20. doi: 10.4014/jmb.1807.06061. [Epub ahead of print]

3.

Probiotics combined with aminosalicylic acid affiliates remission of ulcerative colitis: A meta-analysis of randomized controlled trial.

Peng L, Zhong Y, Wu A, Jiang Z.

Biosci Rep. 2018 Sep 17. pii: BSR20180943. doi: 10.1042/BSR20180943. [Epub ahead of print]

PMID:
30224379
4.

Possibilities of therapeutic manipulation of the gut microbiota.

Drastich P, Bajer L, Kverka M.

Vnitr Lek. 2018 Summer;64(6):665-671.

PMID:
30223665
5.

Conventional and biological therapy for inflammatory bowel disease.

BortlĂ­k M.

Vnitr Lek. 2018 Summer;64(6):642-653.

PMID:
30223662
6.

Nonbiological therapeutic management of ulcerative colitis.

Mezzina N, Campbell Davies SE, Ardizzone S.

Expert Opin Pharmacother. 2018 Sep 15:1-11. doi: 10.1080/14656566.2018.1525361. [Epub ahead of print]

PMID:
30220228
7.

Lactobacillus reuteri F-9-35 Prevents DSS-Induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice.

Sun MC, Zhang FC, Yin X, Cheng BJ, Zhao CH, Wang YL, Zhang ZZ, Hao HW, Zhang TH, Ye HQ.

J Food Sci. 2018 Oct;83(10):2645-2652. doi: 10.1111/1750-3841.14326. Epub 2018 Sep 14.

PMID:
30216448
8.

Periplaneta americana Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Rats by Keap1/Nrf-2 Activation, Intestinal Barrier Function, and Gut Microbiota Regulation.

Ma X, Hu Y, Li X, Zheng X, Wang Y, Zhang J, Fu C, Geng F.

Front Pharmacol. 2018 Aug 22;9:944. doi: 10.3389/fphar.2018.00944. eCollection 2018.

9.

Enteric Virome and Bacterial Microbiota in Children with Ulcerative Colitis and Crohn's Disease.

Fernandes MA, Verstraete SG, Phan TG, Deng X, Stekol E, LaMere B, Lynch SV, Heyman MB, Delwart E.

J Pediatr Gastroenterol Nutr. 2018 Aug 30. doi: 10.1097/MPG.0000000000002140. [Epub ahead of print]

PMID:
30169455
10.

The Use of Complementary and Alternative Medicine in Patients With Inflammatory Bowel Disease.

Lin SC, Cheifetz AS.

Gastroenterol Hepatol (N Y). 2018 Jul;14(7):415-425.

11.

Clostridium butyricum promotes intestinal motility by regulation of TLR2 in interstitial cells of Cajal.

Sui SJ, Tian ZB, Wang QC, Chen R, Nie J, Li JS, Wei LZ.

Eur Rev Med Pharmacol Sci. 2018 Jul;22(14):4730-4738. doi: 10.26355/eurrev_201807_15533.

PMID:
30058712
12.

Table: drugs for ulcerative colitis.

[No authors listed]

Med Lett Drugs Ther. 2018 Jul 2;60(1550):e114. No abstract available.

PMID:
30036353
13.

Drugs for inflammatory bowel disease.

[No authors listed]

Med Lett Drugs Ther. 2018 Jul 2;60(1550):107-114. No abstract available.

PMID:
30036352
14.

Probiotics in Pediatric Gastroenterology: Emerging Indications: Inflammatory Bowel Diseases.

Scarpato E, Russo M, Staiano A.

J Clin Gastroenterol. 2018 Nov/Dec;52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017:S7-S9. doi: 10.1097/MCG.0000000000001095.

PMID:
30036240
15.

[Crohn's Disease - New Therapies].

Klag T, Wehkamp J.

Dtsch Med Wochenschr. 2018 Jul;113(13):953-959. doi: 10.1055/a-0538-3671. Epub 2018 Jul 4. Review. German.

PMID:
29972839
16.

Effect of fermented vegetable beverage containing Pediococcus pentosaceus in patients with mild to moderate ulcerative colitis.

Bamba S, Takahashi K, Imaeda H, Nishida A, Kawahara M, Inatomi O, Sugimoto M, Sasaki M, Andoh A.

Biomed Rep. 2018 Jul;9(1):74-80. doi: 10.3892/br.2018.1099. Epub 2018 May 18.

17.

Probiotics in Gastroenterology: How Pro Is the Evidence in Adults?

Koretz RL.

Am J Gastroenterol. 2018 Aug;113(8):1125-1136. doi: 10.1038/s41395-018-0138-0. Epub 2018 Jun 19. Review.

PMID:
29915396
18.

Probiotics for inflammatory bowel diseases: a promising adjuvant treatment.

Coqueiro AY, Raizel R, Bonvini A, Tirapegui J, Rogero MM.

Int J Food Sci Nutr. 2018 May 28:1-10. doi: 10.1080/09637486.2018.1477123. [Epub ahead of print]

PMID:
29804478
19.

A Probiotic for Ulcerative Colitis: The Culture Wars Continue.

Abraham BP, Quigley EMM.

Dig Dis Sci. 2018 Jul;63(7):1678-1680. doi: 10.1007/s10620-018-5097-1. No abstract available.

PMID:
29785650
20.

Review of Saccharomyces boulardii as a treatment option in IBD.

Sivananthan K, Petersen AM.

Immunopharmacol Immunotoxicol. 2018 May 17:1-11. doi: 10.1080/08923973.2018.1469143. [Epub ahead of print]

PMID:
29771163

Supplemental Content

Loading ...
Support Center